April 01, 1996; 46 (4) VIEWS AND REVIEWS
Defining the clinical course of multiple sclerosis
Results of an international survey
Fred D. Lublin, Stephen C. Reingold, National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis*
First published April 1, 1996, DOI: https://doi.org/10.1212/WNL.46.4.907
Fred D. Lublin
*See page for Committee members.
MDStephen C. Reingold
PhD
Defining the clinical course of multiple sclerosis
Results of an international survey
Fred D. Lublin, Stephen C. Reingold, National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis*
Neurology Apr 1996, 46 (4) 907-911; DOI: 10.1212/WNL.46.4.907
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 46 no. 4 907-911
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published April 1, 1996.
Copyright & Usage:
Copyright 1996 by Advanstar Communications Inc.
Author Disclosures
- Fred D. Lublin, MD,
- Stephen C. Reingold, PhD;
- National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis*
- Fred D. Lublin, MD,
- Stephen C. Reingold, PhD;
- National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis*
- *See page 910 for Committee members.
- From the Department of Neurology (Dr. Lublin), Jefferson Medical College, Philadelphia, PA; and the Research and Medical Programs Department (Dr. Reingold), National Multiple Sclerosis Society (USA), New York, NY.
- Received August 9, 1995. Accepted in final form August 18, 1995.
- Address correspondence and reprint requests to Dr Lublin, Department of Neurology, Jefferson Medical College, Philadelphia, PA.
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Views & Reviews
Defining the clinical course of multiple sclerosisThe 2013 revisionsFred D. Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al.Neurology, May 28, 2014 -
Articles
Familial effects on the clinical course of multiple sclerosisA. E. Hensiek, S. R. Seaman, L. F. Barcellos et al.Neurology, January 29, 2007 -
Articles
Age and disability accumulation in multiple sclerosisA. Scalfari, A. Neuhaus, M. Daumer et al.Neurology, September 14, 2011 -
Articles
Impact of multiple sclerosis relapses on progression diminishes with timeH. Tremlett, M. Yousefi, V. Devonshire et al.Neurology, November 04, 2009